Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 9A98G002
Published by: Ivey Publishing
Originally published in: 1998
Version: 1998-01-29
Length: 25 pages
Data source: Field research

Abstract

A Hungarian Pharmaceuticals producer/wholesaler is attempting to enter the retail ''drugstore'' industry, an industry that does not yet exist in Hungary. Hungary has strict laws defining what can be sold in a pharmacy and a ''druggery,'' (which are two separate entities), yet PharmaPlus, (no connection with the North American chain Pharma Plus Drugmart), is attempting to combine the two with its one existing store. Management of PharmaPlus are facing opposition from the regulatory body of pharmacists which has authority over a pharmacy''s operations and the stakeholders in the current industry structure, despite having the support of the Minister of Health and strong evidence that the concept is popular with customers. The case deals with issues of lobbying the stakeholders who have power, finding a sustainable competitive advantage in a market that has never seen this type of business, the idea of a global concept of service, shaping an industry to one''s own advantage, an industry of pure competition (many players), and potential international expansion and the impact of Hungary entering the EU.
Location:
Size:
Medium

About

Abstract

A Hungarian Pharmaceuticals producer/wholesaler is attempting to enter the retail ''drugstore'' industry, an industry that does not yet exist in Hungary. Hungary has strict laws defining what can be sold in a pharmacy and a ''druggery,'' (which are two separate entities), yet PharmaPlus, (no connection with the North American chain Pharma Plus Drugmart), is attempting to combine the two with its one existing store. Management of PharmaPlus are facing opposition from the regulatory body of pharmacists which has authority over a pharmacy''s operations and the stakeholders in the current industry structure, despite having the support of the Minister of Health and strong evidence that the concept is popular with customers. The case deals with issues of lobbying the stakeholders who have power, finding a sustainable competitive advantage in a market that has never seen this type of business, the idea of a global concept of service, shaping an industry to one''s own advantage, an industry of pure competition (many players), and potential international expansion and the impact of Hungary entering the EU.

Settings

Location:
Size:
Medium

Related